Microbial imbalance and intestinal pathologies: Connections and contributions

DMM Disease Models and Mechanisms

Volumn 7, Issue 10, 2014, Pages 1131-1142

  Yang, Ye ^a   Jobin, Christian ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Adherent invasive E. Coli; Colibactin; CRC; Dysbiosis; IBD

Indexed keywords

ADAPTIVE IMMUNITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL VIRULENCE; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; DISORDERS OF CARBOHYDRATE METABOLISM; DNA DAMAGE; DYSBIOSIS; ESCHERICHIA COLI; GENOMIC INSTABILITY; HOST; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIAL ACTIVITY; MICROBIAL COMMUNITY; MICROBIAL IMBALANCE; NONHUMAN; PROTEIN SECRETION; PROTEOBACTERIA; REVIEW; UPREGULATION; ENTEROPATHY; ESCHERICHIA COLI INFECTION; MICROBIOLOGY; MICROFLORA; PATHOLOGY;

ESCHERICHIA COLI INFECTIONS; HUMANS; INTESTINAL DISEASES; MICROBIOTA;

EID: 84907525188     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.016428     Document Type: Review

References (164)

1. Adolph, T. E., Tomczak, M. F., Niederreiter, L., Ko, H. J., Böck, J., Martinez-Naves, E., Glickman, J. N., Tschurtschenthaler, M., Hartwig, J., Hosomi, S. et al. (2013). Paneth cells as a site of origin for intestinal inflammation. Nature 503, 272-276.
2. Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B. and Yang, L. (2013). Human gut microbiome and risk for colorectal cancer. J. Natl. Cancer Inst. 105, 1907-1911.
3. Alpert, C., Scheel, J., Engst, W., Loh, G. and Blaut, M. (2009). Adaptation of protein expression by Escherichia coli in the gastrointestinal tract of gnotobiotic mice. Environ. Microbiol. 11, 751-761.
4. Apperloo-Renkema, H. Z., Van der Waaij, B. D. and Van der Waaij, D. (1990). Determination of colonization resistance of the digestive tract by biotyping of Enterobacteriaceae. Epidemiol. Infect. 105, 355-361.
5. Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J. et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451-455.
6. Arthur, J. C. and Jobin, C. (2013). The complex interplay between inflammation, the microbiota and colorectal cancer. Gut Microbes 4, 253-258.
7. Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T. J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B. et al. (2012). Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338, 120-123.
8. Arthur, J. C., Gharaibeh, R. Z., Mühlbauer, M., Perez-Chanona, E., Uronis, J. M., McCafferty, J., Fordor, A. A. and Jobin, C. (2014). Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer. Nat. Commun. (in press) DOI:10.1038/ncomms5724.
9. Atarashi, K., Tanoue, T., Shima, T., Imaoka, A., Kuwahara, T., Momose, Y., Cheng, G., Yamasaki, S., Saito, T., Ohba, Y. et al. (2011). Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341.
10. Barbas, A. S., Lesher, A. P., Thomas, A. D., Wyse, A., Devalapalli, A. P., Lee, Y. H., Tan, H. E., Orndorff, P. E., Bollinger, R. R. and Parker, W. (2009). Altering and assessing persistence of genetically modified E. coli MG1655 in the large bowel. Exp. Biol. Med. (Maywood) 234, 1174-1185.
11. Barnich, N., Boudeau, J., Claret, L. and Darfeuille-Michaud, A. (2003). Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol. Microbiol. 48, 781-794.
12. Barnich, N., Carvalho, F. A., Glasser, A. L., Darcha, C., Jantscheff, P., Allez, M., Peeters, H., Bommelaer, G., Desreumaux, P., Colombel, J. F. et al. (2007). CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J. Clin. Invest. 117, 1566-1574.
13. Bates, J. M., Akerlund, J., Mittge, E. and Guillemin, K. (2007). Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe 2, 371-382.
14. Baumgart, D. C. and Sandborn, W. J. (2012). Crohn's disease. Lancet 380, 1590-1605.
15. Baumgart, M., Dogan, B., Rishniw, M., Weitzman, G., Bosworth, B., Yantiss, R., Orsi, R. H., Wiedmann, M., McDonough, P., Kim, S. G. et al. (2007). Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J. 1, 403-418.
16. Belcheva, A., Irrazabal, T., Robertson, S. J., Streutker, C., Maughan, H., Rubino, S., Moriyama, E. H., Copeland, J. K., Kumar, S., Green, B. et al. (2014). Gut microbial metabolism drives transformation of msh2-deficient colon epithelial cells. Cell 158, 288-299.
17. Bergstrom, K. S., Kissoon-Singh, V., Gibson, D. L., Ma, C., Montero, M., Sham, H. P., Ryz, N., Huang, T., Velcich, A., Finlay, B. B. et al. (2010). Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog. 6, e1000902.
18. Bertin, Y., Girardeau, J. P., Chaucheyras-Durand, F., Lyan, B., Pujos-Guillot, E., Harel, J. and Martin, C. (2011). Enterohaemorrhagic Escherichia coli gains a competitive advantage by using ethanolamine as a nitrogen source in the bovine intestinal content. Environ. Microbiol. 13, 365-377.
19. Boleij, A. and Tjalsma, H. (2012). Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. Camb. Philos. Soc. 87, 701-730.
20. Bollinger, R. R., Everett, M. L., Palestrant, D., Love, S. D., Lin, S. S. and Parker, W. (2003). Human secretory immunoglobulin A may contribute to biofilm formation in the gut. Immunology 109, 580-587.
21. Bollinger, R. R., Everett, M. L., Wahl, S. D., Lee, Y. H., Orndorff, P. E. and Parker, W. (2006). Secretory I and mucin-mediated biofilm formation by environmental strains of Escherichia coli: role of type 1 pili. Mol. Immunol. 43, 378-387.
22. Bonnet, M., Buc, E., Sauvanet, P., Darcha, C., Dubois, D., Pereira, B., Déchelotte, P., Bonnet, R., Pezet, D. and Darfeuille-Michaud, A. (2014). Colonization of the human gut by E. coli and colorectal cancer risk. Clin. Cancer Res. 20, 859-867.
23. Boudeau, J., Glasser, A. L., Masseret, E., Joly, B. and Darfeuille-Michaud, A. (1999). Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect. Immun. 67, 4499-4509.
24. Boudeau, J., Barnich, N. and Darfeuille-Michaud, A. (2001). Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol. Microbiol. 39, 1272-1284.
25. Bringer, M. A., Billard, E., Glasser, A. L., Colombel, J. F. and Darfeuille-Michaud, A. (2012). Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion. Lab. Invest. 92, 411-419.
26. Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D. and Bonnet, R. (2013). High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE 8, e56964.
27. Carvalho, F. A., Koren, O., Goodrich, J. K., Johansson, M. E., Nalbantoglu, I., Aitken, J. D., Su, Y., Chassaing, B., Walters, W. A., González, A. et al. (2012). Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host Microbe 12, 139-152.
28. Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A. et al. (2012). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299-306.
29. CCFA. (2011). Facts about Inflammatory Bowel Diseases. New York, NY: CCFA.
30. Cerutti, A. and Rescigno, M. (2008). The biology of intestinal immunoglobulin A responses. Immunity 28, 740-750.
31. Chang, D. E., Smalley, D. J., Tucker, D. L., Leatham, M. P., Norris, W. E., Stevenson, S. J., Anderson, A. B., Grissom, J. E., Laux, D. C., Cohen, P. S. et al. (2004). Carbon nutrition of Escherichia coli in the mouse intestine. Proc. Natl. Acad. Sci. USA 101, 7427-7432.
32. Chassaing, B. and Darfeuille-Michaud, A. (2011). The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728.e3.
33. Chen, W., Liu, F., Ling, Z., Tong, X. and Xiang, C. (2012). Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7, e39743.
34. Clemente, J. C., Ursell, L. K., Parfrey, L. W. and Knight, R. (2012). The impact of the gut microbiota on human health: an integrative view. Cell 148, 1258-1270.
35. Clements, A., Young, J. C., Constantinou, N. and Frankel, G. (2012). Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes 3, 71-87.
36. Conway, T., Krogfelt, K. A. and Cohen, P. S. (2004). The life of commensal escherichia coli in the mammalian intestine. In EcoSal-Escherichia Coli and Salmonella: Cellular and Molecular Biology (ed. R. Curtiss III). Washington, DC: ASM Press.
37. Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I. and Knight, R. (2009). Bacterial community variation in human body habitats across space and time. Science 326, 1694-1697.
38. Cougnoux, A., Dalmasso, G., Martinez, R., Buc, E., Delmas, J., Gibold, L., Sauvanet, P., Darcha, C., Déchelotte, P., Bonnet, M. et al. (2014). Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut.
39. Cuevas-Ramos, G., Petit, C. R., Marcq, I., Boury, M., Oswald, E. and Nougayrède, J. P. (2010). Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc. Natl. Acad. Sci. USA 107, 11537-11542.
40. Cunliffe, R. N. and Mahida, Y. R. (2004). Expression and regulation of antimicrobial peptides in the gastrointestinal tract. J. Leukoc. Biol. 75, 49-58.
41. D'Haens, G. R., Geboes, K., Peeters, M., Baert, F., Penninckx, F. and Rutgeerts, P. (1998). Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262-267.
42. D'Incà, R., Annese, V., di Leo, V., Latiano, A., Quaino, V., Abazia, C., Vettorato, M. G. and Sturniolo, G. C. (2006). Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment. Pharmacol. Ther. 23, 1455-1461.
43. Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A. and Colombel, J. F. (1998). Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 115, 1405-1413.
44. Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A. L., Barnich, N., Bringer, M. A., Swidsinski, A., Beaugerie, L. and Colombel, J. F. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127, 412-421.
45. De la Fuente, M., Franchi, L., Araya, D., Díaz-Jiménez, D., Olivares, M., Álvarez-Lobos, M., Golenbock, D., González, M. J., López-Kostner, F., Quera, R. et al. (2014). Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int. J. Med. Microbiol. 304, 384-392.
46. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E. and Relman, D. A. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
47. Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C. and Flavell, R. A. (2013). Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat. Rev. Cancer 13, 759-771.
48. Elliott, T. R., Hudspith, B. N., Wu, G., Cooley, M., Parkes, G., Quiñones, B., Randall, L., Mandrell, R. E., Fagerquist, C. K., Brostoff, J. et al. (2013). Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease. Inflamm. Bowel Dis. 19, 2326-2338.
49. Esteban-Jurado, C., Garre, P., Vila, M., Lozano, J. J., Pristoupilova, A., Beltrán, S., Abulí, A., Muñoz, J., Balaguer, F., Ocaña, T. et al. (2014). New genes emerging for colorectal cancer predisposition. World J. Gastroenterol. 20, 1961-1971.
50. Fabbri, A., Travaglione, S., Ballan, G., Loizzo, S. and Fiorentini, C. (2013). The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. Toxins (Basel) 5, 1462-1474.
51. Fabich, A. J., Jones, S. A., Chowdhury, F. Z., Cernosek, A., Anderson, A., Smalley, D., McHargue, J. W., Hightower, G. A., Smith, J. T., Autieri, S. M. et al. (2008). Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect. Immun. 76, 1143-1152.
52. Feagins, L. A., Souza, R. F. and Spechler, S. J. (2009). Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 6, 297-305.
53. Feller, M., Huwiler, K., Schoepfer, A., Shang, A., Furrer, H. and Egger, M. (2010). Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials. Clin. Infect. Dis. 50, 473-480.
54. Fox, J. G., Rogers, A. B., Whary, M. T., Ge, Z., Taylor, N. S., Xu, S., Horwitz, B. H. and Erdman, S. E. (2004). Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains. Infect. Immun. 72, 1116-1125.
55. Freestone, P. P., Walton, N. J., Haigh, R. D. and Lyte, M. (2007). Influence of dietary catechols on the growth of enteropathogenic bacteria. Int. J. Food Microbiol. 119, 159-169.
56. Fukata, M., Chen, A., Vamadevan, A. S., Cohen, J., Breglio, K., Krishnareddy, S., Hsu, D., Xu, R., Harpaz, N., Dannenberg, A. J. et al. (2007). Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133, 1869-1869.e14.
57. Fukata, M., Shang, L., Santaolalla, R., Sotolongo, J., Pastorini, C., España, C., Ungaro, R., Harpaz, N., Cooper, H. S., Elson, G. et al. (2011). Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm. Bowel Dis. 17, 1464-1473.
58. Fukuda, S., Toh, H., Hase, K., Oshima, K., Nakanishi, Y., Yoshimura, K., Tobe, T., Clarke, J. M., Topping, D. L., Suzuki, T. et al. (2011). Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543-547.
59. Fukuda, S., Toh, H., Taylor, T. D., Ohno, H. and Hattori, M. (2012). Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3, 449-454.
60. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T. et al. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450.
61. Garg, A. D., Kaczmarek, A., Krysko, O., Vandenabeele, P., Krysko, D. V. and Agostinis, P. (2012). ER stress-induced inflammation: does it aid or impede disease progression? Trends Mol. Med. 18, 589-598.
62. Garrett, W. S., Gallini, C. A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M. L., Punit, S., Karlsson, M., Bry, L., Glickman, J. N. et al. (2010). Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8, 292-300.
63. Garsin, D. A. (2010). Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat. Rev. Microbiol. 8, 290-295.
64. Glasser, A. L., Boudeau, J., Barnich, N., Perruchot, M. H., Colombel, J. F. and Darfeuille-Michaud, A. (2001). Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect. Immun. 69, 5529-5537.
65. Grivennikov, S. I. (2013). Inflammation and colorectal cancer: colitis-associated neoplasia. Semin. Immunopathol. 35, 229-244.
66. Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G. Y., Osterreicher, C. H., Hung, K. E. et al. (2012). Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254-258.
67. Guerra, L., Guidi, R. and Frisan, T. (2011). Do bacterial genotoxins contribute to chronic inflammation, genomic instability and tumor progression? FEBS J. 278, 4577-4588.
68. Halme, L., Paavola-Sakki, P., Turunen, U., Lappalainen, M., Farkkila, M. and Kontula, K. (2006). Family and twin studies in inflammatory bowel disease. World J. Gastroenterol. 12, 3668-3672.
69. Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A. D. (2013). Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5, 1869-1912.
70. Henrissat, B. and Davies, G. (1997). Structural and sequence-based classification of glycoside hydrolases. Curr. Opin. Struct. Biol. 7, 637-644.
71. Hepworth, M. R., Monticelli, L. A., Fung, T. C., Ziegler, C. G., Grunberg, S., Sinha, R., Mantegazza, A. R., Ma, H. L., Crawford, A., Angelosanto, J. M. et al. (2013). Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113-117.
72. Herrinton, L. J., Liu, L., Levin, T. R., Allison, J. E., Lewis, J. D. and Velayos, F. (2012). Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 143, 382-389.
73. Hilsden, R. J., Meddings, J. B., Hardin, J., Gall, D. G. and Sutherland, L. R. (1999). Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm. Bowel Dis. 5, 85-91.
74. Høivik, M. L., Moum, B., Solberg, I. C., Henriksen, M., Cvancarova, M., Bernklev, T.; IBSEN Group (2013). Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study. Gut 62, 368-375.
75. Hoskins, L. C., Agustines, M., McKee, W. B., Boulding, E. T., Kriaris, M. and Niedermeyer, G. (1985). Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J. Clin. Invest. 75, 944-953.
76. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M. et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
77. Human Microbiome Project Consortium (2012). Structure, function and diversity of the healthy human microbiome. Nature 486, 207-214.
78. Imlay, J. A. (2013). The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 11, 443-454.
79. Järnerot, G., Tysk, C., Bohr, J. and Eriksson, S. (1995). Collagenous colitis and fecal stream diversion. Gastroenterology 109, 449-455.
80. Jobin, C. (2013). Colorectal cancer: looking for answers in the microbiota. Cancer Discov 3, 384-387.
81. 2mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. USA 105, 15064-15069.
82. Johansson, M. E., Sjövall, H. and Hansson, G. C. (2013). The gastrointestinal mucus system in health and disease. Nat Rev Gastroenterol Hepatol 10, 352-361.
83. Johnson, J. R., Johnston, B., Kuskowski, M. A., Nougayrede, J. P. and Oswald, E. (2008). Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 46, 3906-3911.
84. Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Schumm, L. P., Sharma, Y., Anderson, C. A. et al.; International IBD Genetics Consortium (IIBDGC) (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124.
85. Kamada, N., Seo, S. U., Chen, G. Y. and Núñez, G. (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321-335.
86. Kaser, A., Zeissig, S. and Blumberg, R. S. (2010). Inflammatory bowel disease. Annu. Rev. Immunol. 28, 573-621.
87. Kaser, A., Adolph, T. E. and Blumberg, R. S. (2013). The unfolded protein response and gastrointestinal disease. Semin. Immunopathol. 35, 307-319.
88. Khan, A. A. and Cash, P. (2013). E. coli and colon cancer: is mutY a culprit? Cancer Lett. 341, 127-131.
89. Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J. et al. (2012). Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292-298.
90. Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L. et al. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14, 207-215.
91. Kostic, A. D., Xavier, R. J. and Gevers, D. (2014). The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489-1499.
92. Lapaquette, P., Glasser, A. L., Huett, A., Xavier, R. J. and Darfeuille-Michaud, A. (2010). Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell. Microbiol. 12, 99-113.
93. Leatham-Jensen, M. P., Frimodt-Møller, J., Adediran, J., Mokszycki, M. E., Banner, M. E., Caughron, J. E., Krogfelt, K. A., Conway, T. and Cohen, P. S. (2012). The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota. Infect. Immun. 80, 1716-1727.
94. Lee, S. M., Donaldson, G. P., Mikulski, Z., Boyajian, S., Ley, K. and Mazmanian, S. K. (2013). Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426-429.
95. Lu, C., Chen, J., Xu, H. G., Zhou, X., He, Q., Li, Y. L., Jiang, G., Shan, Y., Xue, B., Zhao, R. X. et al. (2014). MIR106B and MIR93 prevent removal of bacteria from epithelial cells by disrupting ATG16L1-mediated autophagy. Gastroenterology 146, 188-199.
96. Lyte, M., Vulchanova, L. and Brown, D. R. (2011). Stress at the intestinal surface: catecholamines and mucosa-bacteria interactions. Cell Tissue Res. 343, 23-32.
97. Maddocks, O. D., Scanlon, K. M. and Donnenberg, M. S. (2013). An Escherichia coli effector protein promotes host mutation via depletion of DNA mismatch repair proteins. MBio 4, e00152-13.
98. Maltby, R., Leatham-Jensen, M. P., Gibson, T., Cohen, P. S. and Conway, T. (2013). Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. PLoS ONE 8, e53957.
99. Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E., Cui, L., McFaline, J. L., Mobley, M., Ge, Z. et al. (2012). Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc. Natl. Acad. Sci. USA 109, E1820-E1829.
100. Manichanh, C., Borruel, N., Casellas, F. and Guarner, F. (2012). The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9, 599-608.
101. Martin, H. M., Campbell, B. J., Hart, C. A., Mpofu, C., Nayar, M., Singh, R., Englyst, H., Williams, H. F. and Rhodes, J. M. (2004). Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 127, 80-93.
102. Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D. et al. (2009). Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282-1286.
103. McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J. J., Sandler, R. S. and Keku, T. O. (2013). Fusobacterium is associated with colorectal adenomas. PLoS ONE 8, e53653.
104. Miranda, R. L., Conway, T., Leatham, M. P., Chang, D. E., Norris, W. E., Allen, J. H., Stevenson, S. J., Laux, D. C. and Cohen, P. S. (2004). Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect. Immun. 72, 1666-1676.
105. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D., Devaney, K. L., Ward, D. V., Reyes, J. A., Shah, S. A., LeLeiko, N., Snapper, S. B. et al. (2012). Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79.
106. Mukhopadhya, I., Hansen, R., El-Omar, E. M. and Hold, G. L. (2012). IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 9, 219-230.
107. Myhal, M. L., Laux, D. C. and Cohen, P. S. (1982). Relative colonizing abilities of human fecal and K 12 strains of Escherichia coli in the large intestines of streptomycin-treated mice. Eur. J. Clin. Microbiol. 1, 186-192.
108. Netjes, J. E. and Rijken, M. (2013). Labor participation among patients with inflammatory bowel disease. Inflamm. Bowel Dis. 19, 81-91.
109. Ng, S. C., Tsoi, K. K., Kamm, M. A., Xia, B., Wu, J., Chan, F. K. and Sung, J. J. (2012). Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflamm. Bowel Dis. 18, 1164-1176.
110. Nguyen, H. T., Dalmasso, G., Müller, S., Carrière, J., Seibold, F. and Darfeuille-Michaud, A. (2014). Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 146, 508-519.
111. Nougayrède, J. P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U. and Oswald, E. (2006). Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848-851.
112. Nowrouzian, F. L. and Oswald, E. (2012). Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb. Pathog. 53, 180-182.
113. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H. et al. (2001). A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
114. Ordás, I., Eckmann, L., Talamini, M., Baumgart, D. C. and Sandborn, W. J. (2012). Ulcerative colitis. Lancet 380, 1606-1619.
115. Packey, C. D. and Sartor, R. B. (2009). Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr. Opin. Infect. Dis. 22, 292-301.
116. Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A. and Brown, P. O. (2007). Development of the human infant intestinal microbiota. PLoS Biol. 5, e177.
117. Patwa, L. G., Fan, T. J., Tchaptchet, S., Liu, Y., Lussier, Y. A., Sartor, R. B. and Hansen, J. J. (2011). Chronic intestinal inflammation induces stress-response genes in commensal Escherichia coli. Gastroenterology 141, 1842-51.e1-10. PubMed
118. Payros, D., Secher, T., Boury, M., Brehin, C., Ménard, S., Salvador-Cartier, C., Ceevas-Ramos, G., Watrin, C., Marcq, I., Nougayrède, J. P. et al. (2014). Maternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis. Gut Microbes 5, 1-13.
119. Prideaux, L., Kamm, M. A., De Cruz, P. P., Chan, F. K. and Ng, S. C. (2012). Inflammatory bowel disease in Asia: a systematic review. J. Gastroenterol. Hepatol. 27, 1266-1280. PubMed
120. Putze, J., Hennequin, C., Nougayrède, J. P., Zhang, W., Homburg, S., Karch, H., Bringer, M. A., Fayolle, C., Carniel, E., Rabsch, W. et al. (2009). Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect. Immun. 77, 4696-4703.
121. Rolhion, N., Barnich, N., Bringer, M. A., Glasser, A. L., Ranc, J., Hébuterne, X., Hofman, P. and Darfeuille-Michaud, A. (2010). Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut 59, 1355-1362.
122. Rooks, M. G., Veiga, P., Wardwell-Scott, L. H., Tickle, T., Segata, N., Michaud, M., Gallini, C. A., Beal, C., van Hylckama-Vlieg, J. E., Ballal, S. A. et al. (2014). Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 8, 1403-1417.
123. Round, J. L., Lee, S. M., Li, J., Tran, G., Jabri, B., Chatila, T. A. and Mazmanian, S. K. (2011). The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974-977.
124. Roy, K., Anba, J., Corthier, G., Rigottier-Gois, L., Monnet, V. and Mistou, M. Y. (2008). Metabolic adaptation of Lactococcus lactis in the digestive tract: the example of response to lactose. J. Mol. Microbiol. Biotechnol. 14, 137-144.
125. Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G. and Han, Y. W. (2013). Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/â-catenin signaling via its FadA adhesin. Cell Host Microbe 14, 195-206.
126. Rustgi, A. K. (2007). The genetics of hereditary colon cancer. Genes Dev. 21, 2525-2538.
127. Rutgeerts, P., Goboes, K., Peeters, M., Hiele, M., Penninckx, F., Aerts, R., Kerremans, R. and Vantrappen, G. (1991). Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338, 771-774.
128. Salzman, N. H., Hung, K., Haribhai, D., Chu, H., Karlsson-Sjöberg, J., Amir, E., Teggatz, P., Barman, M., Hayward, M., Eastwood, D. et al. (2010). Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11, 76-82.
129. Schumann, S., Alpert, C., Engst, W., Loh, G. and Blaut, M. (2012). Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model. Appl. Environ. Microbiol. 78, 1513-1522.
130. Schumann, S., Alpert, C., Engst, W., Klopfleisch, R., Loh, G., Bleich, A. and Blaut, M. (2013). Mild gut inflammation modulates the proteome of intestinal Escherichia coli. Environ. Microbiol.
131. Schwabe, R. F. and Jobin, C. (2013). The microbiome and cancer. Nat. Rev. Cancer 13, 800-812.
132. Sears, C. L. and Garrett, W. S. (2014). Microbes, microbiota, and colon cancer. Cell Host Microbe 15, 317-328.
133. Sears, C. L. and Pardoll, D. M. (2011). Perspective: alpha-bugs, their microbial partners, and the link to colon cancer. J. Infect. Dis. 203, 306-311.
134. Secher, T., Samba-Louaka, A., Oswald, E. and Nougayrède, J. P. (2013). Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLoS ONE 8, e77157.
135. Selby, W., Pavli, P., Crotty, B., Florin, T., Radford-Smith, G., Gibson, P., Mitchell, B., Connell, W., Read, R., Merrett, M. et al.; Antibiotics in Crohn's Disease Study Group (2007). Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease. Gastroenterology 132, 2313-2319.
136. Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M. and Sartor, R. B. (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224-5231.
137. Sharma, V. K. and Bearson, S. M. (2013). Evaluation of the impact of quorum sensing transcriptional regulator SdiA on long-term persistence and fecal shedding of Escherichia coli O157:H7 in weaned calves. Microb. Pathog. 57, 21-26.
138. Sharma, V. K. and Casey, T. A. (2014). Escherichia coli O157:H7 lacking the qseBC-encoded quorum-sensing system outcompetes the parental strain in colonization of cattle intestines. Appl. Environ. Microbiol. 80, 1882-1892.
139. Shen, Z., Feng, Y., Rogers, A. B., Rickman, B., Whary, M. T., Xu, S., Clapp, K. M., Boutin, S. R. and Fox, J. G. (2009). Cytolethal distending toxin promotes Helicobacter cinaedi-associated typhlocolitis in interleukin-10-deficient mice. Infect. Immun. 77, 2508-2516.
140. Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014). Cancer statistics, 2014. CA Cancer J. Clin. 64, 9-29.
141. Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H. et al. (2014). Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139.
142. Slack, E., Hapfelmeier, S., Stecher, B., Velykoredko, Y., Stoel, M., Lawson, M. A., Geuking, M. B., Beutler, B., Tedder, T. F., Hardt, W. D. et al. (2009). Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325, 617-620.
143. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N. and Garrett, W. S. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573.
144. Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Tran Van Nhieu, J. and Furet, J. P. (2011). Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS ONE 6, e16393.
145. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J. J., Blugeon, S., Bridonneau, C., Furet, J. P., Corthier, G. et al. (2008). Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105, 16731-16736.
146. Song, X., Gao, H., Lin, Y., Yao, Y., Zhu, S., Wang, J., Liu, Y., Yao, X., Meng, G., Shen, N. et al. (2014). Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity 40, 140-152.
147. Spees, A. M., Wangdi, T., Lopez, C. A., Kingsbury, D. D., Xavier, M. N., Winter, S. E., Tsolis, R. M. and Bäumler, A. J. (2013). Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. MBio 4, e00430-13.
148. Strober, W. (2013). Impact of the gut microbiome on mucosal inflammation. Trends Immunol. 34, 423-430.
149. Sweeney, N. J., Klemm, P., McCormick, B. A., Moller-Nielsen, E., Utley, M., Schembri, M. A., Laux, D. C. and Cohen, P. S. (1996a). The Escherichia coli K-12 gntP gene allows E. coli F-18 to occupy a distinct nutritional niche in the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3497-3503.
150. Sweeney, N. J., Laux, D. C. and Cohen, P. S. (1996b). Escherichia coli F-18 and E. coli K-12 eda mutants do not colonize the streptomycin-treated mouse large intestine. Infect. Immun. 64, 3504-3511.
151. Thia, K. T., Mahadevan, U., Feagan, B. G., Wong, C., Cockeram, A., Bitton, A., Bernstein, C. N. and Sandborn, W. J. (2009). Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm. Bowel Dis. 15, 17-24.
152. Vogel-Scheel, J., Alpert, C., Engst, W., Loh, G. and Blaut, M. (2010). Requirement of purine and pyrimidine synthesis for colonization of the mouse intestine by Escherichia coli. Appl. Environ. Microbiol. 76, 5181-5187.
153. Wadolkowski, E. A., Laux, D. C. and Cohen, P. S. (1988). Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect. Immun. 56, 1030-1035.
154. Watson, I. R., Takahashi, K., Futreal, P. A. and Chin, L. (2013). Emerging patterns of somatic mutations in cancer. Nat. Rev. Genet. 14, 703-718.
155. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R. et al. (2005). Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102, 18129-18134.
156. Wine, E., Ossa, J. C., Gray-Owen, S. D. and Sherman, P. M. (2009). Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol. 9, 180.
157. Winter, S. E., Thiennimitr, P., Winter, M. G., Butler, B. P., Huseby, D. L., Crawford, R. W., Russell, J. M., Bevins, C. L., Adams, L. G., Tsolis, R. M. et al. (2010). Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467, 426-429.
158. Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D. et al. (2013). Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339, 708-711.
159. Wu, S., Rhee, K. J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H. R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F. et al. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022.
160. Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z. et al. (2013). Dysbiosis signature of fecal microbiota in colorectal cancer patients. Microb. Ecol. 66, 462-470.
161. Wyatt, J., Vogelsang, H., Hübl, W., Waldhöer, T. and Lochs, H. (1993). Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341, 1437-1439.
162. Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P. et al. (2012). Human gut microbiome viewed across age and geography. Nature 486, 222-227.
163. Yuan, J., Wang, B., Sun, Z., Bo, X., Yuan, X., He, X., Zhao, H., Du, X., Wang, F., Jiang, Z. et al. (2008). Analysis of host-inducing proteome changes in bifidobacterium longum NCC2705 grown in vivo. J. Proteome Res. 7, 375-385.
164. Zhan, Y., Chen, P. J., Sadler, W. D., Wang, F., Poe, S., Núñez, G., Eaton, K. A. and Chen, G. Y. (2013). Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res. 73, 7199-7210.